2017
DOI: 10.1186/s12918-017-0492-3
|View full text |Cite
|
Sign up to set email alerts
|

GoldenPiCS: a Golden Gate-derived modular cloning system for applied synthetic biology in the yeast Pichia pastoris

Abstract: BackgroundState-of-the-art strain engineering techniques for the host Pichia pastoris (syn. Komagataella spp.) include overexpression of homologous and heterologous genes, and deletion of host genes. For metabolic and cell engineering purposes the simultaneous overexpression of more than one gene would often be required. Very recently, Golden Gate based libraries were adapted to optimize single expression cassettes for recombinant proteins in P. pastoris. However, an efficient toolbox allowing the overexpressi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
167
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 129 publications
(170 citation statements)
references
References 42 publications
2
167
0
1
Order By: Relevance
“…eGFP was used to screen for the AOX1 promoter expression levels. The linearized vector ( Asc I) BB3aN_pAOX1_eGFP_CycTT was transformed into the AOX1 terminator (Prielhofer et al, 2017) and selected on YPD plates with 100 ug/mL nourseothricin. For secreted protein production, the Mut S and Mut − strains were transformed with the pPM2pN21_pAOX1_HSAopt_CycTT vector (Mut − P AOX1 HSA & Mut S P AOX1 HSA), carrying codon‐optimized human serum albumin (HSA) with the native secretion sequence (Puxbaum, Gasser, & Mattanovich, 2016) and the pPM2pZ30_pAOX1_αMF‐vHH_CycTT vector (Mut − P AOX1 vHH and Mut S P AOX1 vHH) carrying a codon‐optimized variable region of a camelid antibody (vHH) with a Saccharomyces cerevisiae α‐mating‐type secretion sequence.…”
Section: Methodsmentioning
confidence: 99%
“…eGFP was used to screen for the AOX1 promoter expression levels. The linearized vector ( Asc I) BB3aN_pAOX1_eGFP_CycTT was transformed into the AOX1 terminator (Prielhofer et al, 2017) and selected on YPD plates with 100 ug/mL nourseothricin. For secreted protein production, the Mut S and Mut − strains were transformed with the pPM2pN21_pAOX1_HSAopt_CycTT vector (Mut − P AOX1 HSA & Mut S P AOX1 HSA), carrying codon‐optimized human serum albumin (HSA) with the native secretion sequence (Puxbaum, Gasser, & Mattanovich, 2016) and the pPM2pZ30_pAOX1_αMF‐vHH_CycTT vector (Mut − P AOX1 vHH and Mut S P AOX1 vHH) carrying a codon‐optimized variable region of a camelid antibody (vHH) with a Saccharomyces cerevisiae α‐mating‐type secretion sequence.…”
Section: Methodsmentioning
confidence: 99%
“…All expression cassettes and sgRNA / hCas9 plasmids were constructed by Golden Gate cloning 22,27,28 . Three native genes of P. pastoris ( AOX1 , DAS1 and DAS2 ) were replaced by the coding sequences of the genes listed in Supplementary Table 4.…”
Section: Methodsmentioning
confidence: 99%
“…alcohol oxidase 1 (Aox1)). Powerful genetic tools including CRISPR/Cas9 mediated techniques are available for P. pastoris 17,21,22 allowing to re-build and integrate entire metabolic pathways into this host without the use of integrative selection markers. In this work, we use P. pastoris as a chassis cell to de novo engineer a synthetic CBB cycle and to test its capability to promote autotrophic growth on CO 2 .…”
Section: Introductionmentioning
confidence: 99%
“…Golden Gate cloning is also frequently used for assembly of CRISPR gRNA expression arrays for site‐specific mutagenesis in a variety of organisms (McCarty, Shaw, Ellis, & Ledesma‐Amaro, 2019; Vad‐Nielsen, Lin, Bolund, Nielsen, & Luo, 2016). Finally, Golden Gate cloning has led to the development of the modular cloning system MoClo (Engler et al., 2014; Kowarschik, Hoehenwarter, Marillonnet, & Trujillo, 2018; Weber, Engler, et al., 2011; Werner et al., 2012) and of several other related modular cloning systems (Agmon et al., 2015; Andreou & Nakayama, 2018; Binder et al., 2014; Larroude et al., 2019; Lee, DeLoache, Cervantes, & Dueber, 2015; Martella, Matjusaitis, Auxillos, Pollard, & Cai, 2017; Moore et al., 2016; Occhialini et al., 2019; Pollak et al., 2019; Prielhofer et al., 2017; Sarrion‐Perdigones et al., 2011, 2013).…”
Section: Commentarymentioning
confidence: 99%